Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients

Bone Marrow Transplantation

Volumn 20, Issue 11, 1997, Pages 993-995

  Akiyama, H ^a   Yoshinaga, H ^a   Tanaka, T ^a   Hiruma, K ^a   Tanikawa, S ^a   Sakamaki, H ^a   Onozawa, Y ^a   Wakita, T ^b   Kohara, M ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Bone marrow transplantation; Cyclosporin A; Hepatitis C virus

Indexed keywords

CORE PROTEIN; CYCLOSPORIN A; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; FEMALE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIROGENESIS; VIRUS REACTIVATION;

EID: 0030856839     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700996     Document Type: Article

References (10)

1. Frickhofen N, Wiesneth M, Janita C et al. Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood 1994; 83: 1998-2004.
2. Locasciulli A, Bacigalupo A, Van Lint MT et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 407-411.
3. Ljungman P, Johansson N, Ashan J et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995; 86: 1614-1618.
4. Schuhart MC, Myerson D, Spurgeon CL et al. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors. Bone Marrow Transplant 1996; 17: 601-606.
5. Maruta A, Kanamori H, Fukawa H et al. Liver function tests of recipients with hepatitis C virus infection after bone marrow transplantation. Bone Marrow Transplant 1994; 13: 417-422.
6. Iwarson S, Norkrans G, Wejstal R. Hepatitis C: natural history of a unique infection. Clin Infect Dis 1995; 20: 1361-1370.
7. Tanaka T, Lau JYU, Mizokami M et al. Simple fluorescent immunoassay for detection and quantification of hepatitis C viremia. J Hepatol 1995; 23: 742-745.
8. Tanaka E, Kiyosawa K, Matsumoto A et al. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology 1996; 23: 1330-1333.
9. Fong T, Valinluck B, Govindarajan S et al. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterol 1994; 107: 196-199.
10. Thali M, Bukovsky A, Kondo E et al. Functional association of cyclosporin A with HIV-1 virions. Nature 1994; 372: 363-365.